Structure and Physico-chemical Properties
|
Molecular properties generated using the CDK |
|||||||||||||||||||
Classification  |
|
| Compound class | Synthetic organic |
| Approved drug? | Yes (FDA (2014)) |
| IUPAC Name |
| N-[(1R,2R)-1-(2,3-dihydro-1,4-benzodioxin-7-yl)-1-hydroxy-3-pyrrolidin-1-ylpropan-2-yl]octanamide |
| International Nonproprietary Names |
|
| INN number | INN |
| 9325 | eliglustat |
| Synonyms |
| GENZ-112638 |
| Comments |
| The marketed formulation contains eliglustat tartrate (PubChem CID 52918379). |
| Database Links |
|
| CAS Registry No. | 491833-29-5 |
| ChEMBL Ligand | CHEMBL2110588 |
| GtoPdb PubChem SID | 187051837 |
| PubChem CID | 23652731 |
| Search Google for chemical match using the InChIKey | FJZZPCZKBUKGGU-AUSIDOKSSA-N |
| Search Google for chemicals with the same backbone | FJZZPCZKBUKGGU |
| Search PubMed clinical trials | eliglustat |
| Search PubMed titles | eliglustat |
| Search PubMed titles/abstracts | eliglustat |
| Search UniChem for chemical match using the InChIKey | FJZZPCZKBUKGGU-AUSIDOKSSA-N |
| Search UniChem for chemicals with the same backbone | FJZZPCZKBUKGGU |
| Wikipedia | Eliglustat |
